Novel molecular biomarkers’ response to a cardiac rehabilitation programme in patients with ischaemic heart diseases

References

• Mirdamdi A, Farzamnia H, Varzandeh P, et al. Association between serum homocysteine concentrations with coronary artery disease in Iranian patients. ARYA Atheroscl J. 2011;7:63–67.
   PubMedGoogle Scholar
• Tayal D, Goswami B, Koner BC, et al. Role of homocysteine and apolipoprotein A in atherosclerosis: an update. Biomed Res. 2011; 22:391–405.
   Google Scholar
• Glave E, Castro A, Cordero A, et al. Update in cardiology: vascular risk and cardiac rehabilitation. Rev ESP Cardiol. 2013;66:124–130.
   PubMed Web of Science ®Google Scholar
• Lima LM, Carvalho MDC, Sousa MO. Apo B/Apo A ratio and cardiovascular risk prediction. Arq Bras Cardiol. 2006;88:e140–e 43.
   Google Scholar
• Durington PN. Can measurement of apolipoprotein B replace the lipid profile in the follow up of patients with lipoprotein disorders? Clin Chem. 2002;48:401–402.
   PubMed Web of Science ®Google Scholar
• Reidiger ND, Bruce SG, Young TK. Cardiovascular risk according to plasma apolipoprotein and lipid profiles in a Canadian first nation. Chr Dis Canada. 2010;31:33–38.
   PubMedGoogle Scholar
• Terrados N, Valcarcel G, Venta R. New cardiovascular risk factors and physical activity. Apunts Med Esport. 2010;45:201–208.
   Google Scholar
• Rahim S, Abdullah HM, Ali Y, et al. Serum Apo A1; and its role as a biomarker of coronary artery disease. Cureus. 2016;8:1–11.
   Google Scholar
• Wang Y, Liu J, Jiang Y, et al. Hyperhomocysteinemia is associated with decreased apolipoprotein A1 levels in normal helathy people. BMC Cardiovasc Disord. 2016;16:1–5.
   PubMed Web of Science ®Google Scholar
• Dhamija RK, Gaba P, Arora S, et al. Homocysteine and lipoprotein (a) correlation in ischemic stroke patients. J Neurol Sci. 2009;281: 64–68.
   PubMed Web of Science ®Google Scholar
• Chalghoum A, Noichri Y, Chkioua L, et al. Metabolic interaction between the hyperhomocysteinemia and angiotensin -1 converting enzyme activity in Tunisian patients with coronary artery disease. Ann Bio Clinc. 2012;70:599–604.
   PubMed Web of Science ®Google Scholar
• Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14:6–10.
   PubMed Web of Science ®Google Scholar
• Chalghoum AI, Noichri Y, Karkouch I, et al. Metabolic interaction between hyperhomocysteinemia and endothelin 1 among Tunisian patients with acute coronary disease. Biol Res. 2015; 48:1–6.
   PubMed Web of Science ®Google Scholar
• Barter PJ, Rye K-A. Homocysteine and cardiovascular disease, is HDL the link? Circ Res. 2006;99:565–566.
   PubMed Web of Science ®Google Scholar
• Liu J, Wang Y, Fan H, et al. Hyperhomocysteinaemia is associated with low plasma apolipoprotein A1 levels in patients with impaired glucose tolerance. Diab Vasc Dis Res. 2015;12:298–301.
   PubMed Web of Science ®Google Scholar
• Mikael LG, Genest Jr J, Rozen R. Elevated homocysteine reduces apolipoprotein A1 expression in hyperhomocysteinemic mice and in male with coronary artery disease. Cir Res. 2006;98:564–571.
   PubMed Web of Science ®Google Scholar
• Hosseini SRA, Fathei M, Hejazi K, et al. Effect of combination exercise training on cardiovascular risk factors (adiponection, interleukin- 6, and homocysteine) in sedentary middle aged men. Int J Appl Exer Physiol. 2016;5:55–63.
   Web of Science ®Google Scholar
• Maroto- Sanchez B, Lopez-Torres O, Palacios G, et al. What do we know about homocysteine and exercise? A review from the literature. Clin Chem Lab Med. 2016;54:1561–1577.
   PubMed Web of Science ®Google Scholar
• Deminice R, Ribeiro DF, Frajacomo TT. The effects of acute exercise and exercise training on plasma homocysteine: a meta analysis. PLoS One. 2016;11:e0151653.
   PubMed Web of Science ®Google Scholar
• Shabbir A. Revisiting the relationship between aerobic and static exercise training on cardiovascular risk profiles; a critical review. JBE. 2015;11:55–63.
   Google Scholar
• Sauvageot N, Alkerwi A, Albert A, et al. Use of food frequency questionnaire to assess relationships between dietary habits and cardiovascular risk factors in NESCAV study: validation with biomarkers. Nutr J. 2013;12:1–11.
   PubMed Web of Science ®Google Scholar
• ACSM. ACSM's guidelines for exercise testing and prescription. 7th ed. Philadelphia: Wiliams and Wilkins; 2006.
   Google Scholar
• Brzycki M. Strength testing. Predicting a one- rep max from repetitions to fatigue. J Health Phys Ed Rec Dance. 1993;64:88–90.
   Google Scholar
• Chaudhry S, Kumar N, Behbahani H, et al. Abnormal heart-rate response during cardiopulmonary exercise testing identifies cardiac dysfunction in symptomatic patients with non-obstructive coronary artery disease. Int J Cardiol. 2016;228:114–121.
   PubMed Web of Science ®Google Scholar
• Lira FS, Yamashita AS, Uchida MC, et al. Low and moderate, rather than high intensity strength exercise induce benefit regarding plasma lipid profile. Diabetol Metab Syndr. 2010;2:1–6.
   PubMed Web of Science ®Google Scholar
• Conraads VM, Beckers P, Vaes J, et al. Combined endurance/resistance training reduces NT- ProBNP levels in patients with chronic heart failure. Eur Heart J. 2004;25:1797–1805.
   PubMed Web of Science ®Google Scholar
• Beckers PJ, Denollet J, Possemiers NM, et al. Combined endurance – resistance training versus endurance training in patients with chronic heart failure. A prospective randomized study. Eur Heart J. 2008;29:1829–1860.
   Web of Science ®Google Scholar
• Bouchla A, Karatzanos A, Eleftherios M, et al. Improvements in quadriceps force and work efficiency are related to improvement in endurance capacity following pulmonary rehabilitation in COPP patients. Int Med J. 2011;50:2533–2539.
   Google Scholar
• Kisner C, Colby LA. Therapeutic exercises foundations and techniques. 6th ed. Philadelphia: F A Davis Company; 2012.
   Google Scholar
• American College of Sports Medicine (ACSM). ACSM's guidelines for exercise testing and prescription. 6th ed. Baltimore (MD): Lippincott Williams & Wilkins; 2000.
   Google Scholar
• Dalleck L, Dalleck A. The ACSM exercise intensity guidelines for cardio respiratory fitness: why the misuse? J Exer Physiol. 2008;4:1–11.
   Google Scholar
• Durstine JL, Haskell WL. Effects of training on plasma lipids and lipoproteins. In: Holloszy J O, editor. Exercise and sport science reviews. Baltimore (MD): Williams & Wilkins; 1994. p. 477–521.
   Google Scholar
• Thompson PD, Crouse SF, Goodpaster B, et al. The acute versus the chronic response to exercise. Med Sci Sports Exer. 2001;33:s 438–s 445.
   Web of Science ®Google Scholar
• Lehtonen A, Viikari J, Ehnholm C. The effect of exercise on high density (HDL) lipoprotein apoproteins. Acta Physiol Scand. 1979;106:487–488.
   PubMedGoogle Scholar
• Cui Y, Blumen Thal RS, Flaws JA, et al. Non- high density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med. 2001;161:1413–1419.
   PubMed Web of Science ®Google Scholar
• Thompson PD, Guillinane EM, Sady SP, et al. High density lipoprotein metabolism in endurance athletes and sedentary men. Circulation. 1991;84:140–152.
   PubMed Web of Science ®Google Scholar
• Wilund KR, Colvin PL, Phares P, et al. The effect of endurance exercise training on plasma lipoprotein A1 and lipoprotein A1: AII concentration in sedentary adults. Metabolism. 2002;51: 1053–1060.
   PubMed Web of Science ®Google Scholar
• Tokmakidis S. Training and detraining effect of a combined strength and aerobic exercise program on blood lipids in patients with coronary artery disease. J Cardiopul Rehabili. 2003;23:193–200.
   PubMedGoogle Scholar
• Manning JM, Dooly–Manning R, White K, et al. Effects of resistive training program on lipoprotien lipid levels in obese women. Med Sci Sports Exer. 1991;23:1222–1226.
   PubMedGoogle Scholar
• Davis R, Vance JE. Structure assembly and secretion of lipoproteins. In: Vance DEVAJ, editor. Biochemistry of lipids lipoproteins and membranes. Edmonton (AB, Canada): Elsevier Science Publisher; 1996. p. 473–493.
   Google Scholar
• Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol. 2005;45:1563–1569.
   PubMed Web of Science ®Google Scholar
• Abrams J, Berra K, Blankenship JC, et al. ACCF/AHA/ACP/AATS/PCNA/SCAI/STA guidelines for the diagnosis and management of patients with stable ischemic heart disease. Am J Coll Cardiol 2012;60:e44–e164.
   PubMed Web of Science ®Google Scholar
• Hejazi SM, Reshidlamir A, Jebelli A, et al. The effects of 8 week aerobic exercise on levels of homocysteince, HSCRP serum and plasma fibrinogen in type II diabetic women. Life Sci J. 2013;10:430–435.
   Google Scholar
• Randeva HS, Lewandowski KC, Drzewski J, et al. Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome. J Clin Endo Crinol Metab. 2002;87:4496–4501.
   PubMed Web of Science ®Google Scholar
• Akcakoyun F. Changes in serum lipid profile following moderate exercise. Afry J Pharm Pharmcol. 2010;4:829–833.
   Google Scholar
• Chen CH, Chen YT, Tu HP. Benefits of exercise training and correlation between aerobic capacity and functional outcomes and quality of life in elderly patients with coronary artery disease. Kaohsiung J Med Sci. 2014;30:521–530.
   PubMed Web of Science ®Google Scholar
• Vidoni ML, Gabriel KP, Luo ST. Relationship between homocysteine and muscle strength decline: the Baltimore longitudinal study of aging. J Gerontol A Biol Sci Med Sci. 2018;73:546–551.
   PubMed Web of Science ®Google Scholar